Higher cardiovascular risk observed with beta-blockers in CKD patients without prior cardiovascular disease

Clinical Kidney Journal · Published 2026-06-11 · DOI 10.1093/ckj/sfag204

Free full text

Authors (4)

Seung Hyun Han, Mina Kim, Jungkuk Lee, Sang Youb Han

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Han, S., Kim, M., Lee, J., et al. (2026). Higher cardiovascular risk observed with beta-blockers in CKD patients without prior cardiovascular disease. Clinical Kidney Journal. https://doi.org/10.1093/ckj/sfag204

Related articles

• Patient’s view on: decreasing cardiovascular events after kidney transplantation: a Finnish analysis covering 1990 to 2019 · Clinical Kidney Journal · 2026 · Same journal
• Vitamin K and vascular calcification: from biological plausibility to clinical realism · Clinical Kidney Journal · 2026 · Same journal
• Trends in the management and coding of chronic kidney disease in Spain: cross-sectional analyses of real-life data with a 5-year interval · Clinical Kidney Journal · 2026 · Same journal
• Similar predictive performance and clinical utility of the Kidney Failure Risk Equation using EKFC or CKD-EPI estimated glomerular filtration rate · Clinical Kidney Journal · 2026 · Same journal
• Changing prognostic significance of peritoneal transport status in contemporary incident peritoneal dialysis patients · Clinical Kidney Journal · 2026 · Same journal
• Association between long-term exposure to particulate matter 2.5 and the risk of rapid renal function decline: a prospective study from CHARLS · Clinical Kidney Journal · 2026 · Same journal
• Drowning the kidneys: from fluid overload to physiology-guided fluid management in onco-hematology · Clinical Kidney Journal · 2026 · Same journal
• Improving quality of life in older dialysis patients: the case for broader functional assessment · Clinical Kidney Journal · 2026 · Same journal
• Treatment response to daratumumab in antibody-mediated kidney allograft rejection: evidence from serial protocol biopsies · Clinical Kidney Journal · 2026 · Same journal
• A decade of complement inhibition in post-transplant atypical HUS: outcomes with eculizumab and ravulizumab · Clinical Kidney Journal · 2026 · Same journal